We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$22.2B
AUM Growth
+$2.18B
Cap. Flow
+$152M
Cap. Flow %
0.68%
Top 10 Hldgs %
45.51%
Holding
3,133
New
154
Increased
1,313
Reduced
1,267
Closed
93

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.6M
3
QCOM icon
Qualcomm
QCOM
+$59.1M
4
CME icon
CME Group
CME
+$58M
5
BKNG icon
Booking.com
BKNG
+$54.4M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Financials 10.86%
3 Communication Services 7.23%
4 Consumer Discretionary 7.21%
5 Industrials 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYXS icon
2726
Pyxis Oncology
PYXS
$243M
$1.06K ﹤0.01%
961
+661
+220% +$745
UPB
2727
Upstream Bio Inc
UPB
$405M
$1.05K ﹤0.01%
96
-40
-29% -$369
HBNC icon
2728
Horizon Bancorp
HBNC
$1.03B
$1.05K ﹤0.01%
68
BMEA icon
2729
Biomea Fusion
BMEA
$92.1M
$1.04K ﹤0.01%
579
+285
+97% +$549
RBCAA icon
2730
Republic Bancorp
RBCAA
$1.91B
$1.03K ﹤0.01%
14
VTYX
2731
DELISTED
Ventyx Biosciences
VTYX
$1.03K ﹤0.01%
481
-532
-53% -$859
FSTR icon
2732
Foster
FSTR
$414M
$1.03K ﹤0.01%
47
+26
+124% +$509
KOD icon
2733
Kodiak Sciences
KOD
$2.72B
$1.02K ﹤0.01%
274
-369
-57% -$1.31K
HBIO icon
2734
Harvard Bioscience
HBIO
$28.8M
$1.02K ﹤0.01%
229
+177
+340% +$740
BAER icon
2735
Bridger Aerospace
BAER
$80.6M
$1.01K ﹤0.01%
522
+322
+161% +$495
TRAK icon
2736
ReposiTrak
TRAK
$153M
$1K ﹤0.01%
51
+25
+96% +$524
OTLK icon
2737
Outlook Therapeutics
OTLK
$215M
$994 ﹤0.01%
621
+216
+53% +$344
CMRE icon
2738
Costamare
CMRE
$1.74B
$993 ﹤0.01%
109
-96
-47% -$855
SSTI icon
2739
SoundThinking
SSTI
$105M
$992 ﹤0.01%
76
HUMA icon
2740
Humacyte
HUMA
$201M
$991 ﹤0.01%
474
-221
-32% -$425
BIOA
2741
BioAge Labs
BIOA
$526M
$979 ﹤0.01%
237
+59
+33% +$238
UA icon
2742
Under Armour Class C
UA
$2.42B
$974 ﹤0.01%
150
UP icon
2743
Wheels Up
UP
$191M
$967 ﹤0.01%
45
+17
+61% +$418
TPIC
2744
DELISTED
TPI Composites
TPIC
$944 ﹤0.01%
1,098
+498
+83% +$506
LWAY icon
2745
Lifeway Foods
LWAY
$458M
$937 ﹤0.01%
38
+10
+36% +$237
TCI icon
2746
Transcontinental Realty Investors
TCI
$315M
$937 ﹤0.01%
22
-20
-48% -$679
LFCR icon
2747
Lifecore Biomedical
LFCR
$176M
$934 ﹤0.01%
115
DNTH icon
2748
Dianthus Therapeutics
DNTH
$6.25B
$932 ﹤0.01%
50
-40
-44% -$750
MGX icon
2749
Metagenomi Therapeutics
MGX
$46.3M
$929 ﹤0.01%
628
+95
+18% +$149
ESPR
2750
DELISTED
Esperion Therapeutics
ESPR
$926 ﹤0.01%
+941
New +$942

Similar funds

Nisa Investment Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Nisa Investment Advisors held 3,133 positions worth $22.2B, up 11% from $20B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Nisa Investment Advisors's Q2 2025 filing shows 154 new, 1,313 increased, 1,267 reduced and 93 closed positions. Its largest new stake was iShares Core US Aggregate Bond ETF: 3,987,632 shares worth $396M. The largest sale was NVIDIA, an estimated $65.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Communication Services.

  • Nisa Investment Advisors's largest Q2 2025 buy was iShares Core US Aggregate Bond ETF: 3,987,632 shares worth $396M.
  • Nisa Investment Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $611M increase.
  • Nisa Investment Advisors's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $65.6M.
  • Nisa Investment Advisors fully exited Vanguard FTSE All-World ex-US Small-Cap Index Fund in Q2 2025, selling an estimated $24.3M.
  • Nisa Investment Advisors's ten largest holdings make up 46% of its $22.2B portfolio in Q2 2025.
  • Nisa Investment Advisors opened 154 new positions and closed 93 in Q2 2025.
  • Nisa Investment Advisors's portfolio value rose 11% quarter-over-quarter to $22.2B.

Based on Nisa Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.